Literature DB >> 19951269

Effectiveness of the ketogenic diet in a broad range of seizure types and EEG features for severe childhood epilepsies.

S Beniczky1, M Jose Miranda, J Alving, J Heber Povlsen, P Wolf.   

Abstract

BACKGROUND: Ketogenic diet (KD) is an effective treatment for pharmacoresistant epilepsy: more than half of the patients show a greater than 50% reduction in seizures.
OBJECTIVE: To identify clinical or electroencephalogram (EEG) variables predicting the response to KD.
METHODS: Clinical and EEG data were retrospectively analysed from 50 consecutive patients treated by KD for severe, pharmacoresistant epilepsy. Most of the patients (70%) had retarded mental and motor development.
RESULTS: Three months after the start of the KD two-thirds (33) of the patients were responders (had a more than 50% reduction in seizure frequency). The presence of epileptiform EEG discharges in the temporal region correlated with an unfavourable response (P = 0.03). The presence of bilateral synchronous epileptiform discharges, and the presence of complex partial seizures approached significance but all other variables did not.
CONCLUSIONS: Our results further support that KD is efficient in a wide variety of epileptic patients with a broad range of EEG features. However, patients with epileptiform discharges in the temporal region are less likely to achieve therapeutic response.

Entities:  

Mesh:

Year:  2009        PMID: 19951269     DOI: 10.1111/j.1600-0404.2009.01303.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Dietary therapies for epilepsy and other neurological disorders: highlights of the 3rd international symposium.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

Review 2.  Dietary therapies for epilepsy: future research.

Authors:  Sudha K Kessler; Elizabeth G Neal; Carol S Camfield; Eric H Kossoff
Journal:  Epilepsy Behav       Date:  2011-03-26       Impact factor: 2.937

3.  Early EEG improvement after ketogenic diet initiation.

Authors:  Sudha Kilaru Kessler; Paul R Gallagher; Renée A Shellhaas; Robert R Clancy; A G Christina Bergqvist
Journal:  Epilepsy Res       Date:  2011-02-23       Impact factor: 3.045

4.  Effect of ketogenic diet for drug-resistant epilepsy on immunological cells.

Authors:  May Fouad Nassar; Yasmin Gamal Abdou El-Gendy; Mohamed Tarif Hamza; Marwa Nasser Mohamed; Nesrine Radwan
Journal:  Neurol Sci       Date:  2021-08-27       Impact factor: 3.307

5.  An update on the ketogenic diet, 2012.

Authors:  Ayelet Halevy; Lilach Peleg-Weiss; Roni Cohen; Avinoam Shuper
Journal:  Rambam Maimonides Med J       Date:  2012-01-31

Review 6.  Metabolic Therapy for Temporal Lobe Epilepsy in a Dish: Investigating Mechanisms of Ketogenic Diet using Electrophysiological Recordings in Hippocampal Slices.

Authors:  Masahito Jr Kawamura; David N Ruskin; Susan A Masino
Journal:  Front Mol Neurosci       Date:  2016-11-01       Impact factor: 5.639

7.  Seizure-induced impairment in neuronal ketogenesis: Role of zinc-α2-glycoprotein in mitochondria.

Authors:  Changhong Tan; Xi Liu; Wuxue Peng; Hui Wang; Wen Zhou; Jin Jiang; Xin Wei; Lijuan Mo; Yangmei Chen; Lifen Chen
Journal:  J Cell Mol Med       Date:  2020-04-27       Impact factor: 5.310

8.  Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy.

Authors:  Baomin Li; Lili Tong; Guijuan Jia; Ruopeng Sun
Journal:  Exp Ther Med       Date:  2012-11-22       Impact factor: 2.447

Review 9.  Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis.

Authors:  Hai-Feng Li; Yan Zou; Gangqiang Ding
Journal:  Iran J Pediatr       Date:  2013-12       Impact factor: 0.364

10.  Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: A clinical prospective study.

Authors:  Qiong Wu; Hua Wang; Yu Ying Fan; Jun Mei Zhang; Xue Yan Liu; Xiu Ying Fang; Feng Hua Yang; Qing Jun Cao; Ying Qi
Journal:  Brain Behav       Date:  2018-04-18       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.